HPV (+/-) 子宮頸がんの腫瘍免疫微環境におけるNTRK融合遺伝子の役割
Qiongying Wang1,2, Chan Zhang1,2, Shijia Liu2
1Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
Journal of medical virology
|August 20, 2025
まとめ
NTRK遺伝子の融合は 子宮頸がんの進行を促し,腫瘍の免疫微環境に影響します. これらの融合をターゲットにすることで 子宮頸がん患者の治療に 有望な精密腫瘍学戦略が生まれます
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- 子宮頸がんは,ヒトパピローマウイルス (HPV) と関連付けられている一般的な悪性腫瘍です.
- NTRK遺伝子融合を含む明確な分子変異は,いくつかの子宮頸がんで発生し,腫瘍免疫微環境 (TIME) と治療結果に影響を与えます.
- NTRK融合は腫瘍の進行,侵襲性,および不良の予後に関係しています.
研究 の 目的:
- 子宮頸がんの腫瘍形成における NTRK 遺伝子融合の役割を検討する.
- 細胞信号伝達経路とTIMEに対するNTRK融合の影響を検証する.
- 子宮頸がんにおける HPV 状態と NTRK 融合の相互作用を調査する.
主な方法:
- 子宮頸がんにおけるNTRK融合に関する研究の文献レビュー.
- 分子変異の分析と腫瘍形成への影響
- HPVとNTRK融合に関連した腫瘍免疫微環境 (TIME) の検査.
主要な成果:
- NTRK遺伝子の融合は,子宮頸がんのサブセットで重要な要因として特定されています.
- これらの融合は信号伝達経路に影響を与え 腫瘍の免疫マイクロ環境に 寄与します
- HPV感染とNTRK融合の組み合わせは,疾患の進行に影響します.
結論:
- NTRK融合は子宮頸がんにおける重要な分子要因である.
- NTRK融合,HPV,およびTIMEの相互作用を理解することは,治療開発にとって極めて重要です.
- NTRKを標的とする治療は,子宮頸がんの精密治療の可能性を秘めています.
関連する概念動画
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K


